89 related articles for article (PubMed ID: 23348906)
1. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
[TBL] [Abstract][Full Text] [Related]
2. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
[TBL] [Abstract][Full Text] [Related]
3. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
[TBL] [Abstract][Full Text] [Related]
5. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
[TBL] [Abstract][Full Text] [Related]
6. Incidental FOXL2 mutated adult granulosa cell tumour of the ovary with thecoma-like foci.
Fischer AK; Schömig-Markiefka B; Heydt C; Ratiu D; Mallmann P; Meinel J; Büttner R; Schmidt D; Quaas A
Virchows Arch; 2023 Jul; 483(1):117-124. PubMed ID: 36399188
[TBL] [Abstract][Full Text] [Related]
7. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
[TBL] [Abstract][Full Text] [Related]
8. FOXO1 mitigates the SMAD3/FOXL2
Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
[TBL] [Abstract][Full Text] [Related]
9. Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
Guerrieri C; Hudacko R; Anderson P
Int J Gynecol Pathol; 2023 Sep; 42(5):500-507. PubMed ID: 36044294
[TBL] [Abstract][Full Text] [Related]
10.
Mubeen A; Parra-Herran C
J Clin Pathol; 2023 Dec; 76(12):798-801. PubMed ID: 37798106
[TBL] [Abstract][Full Text] [Related]
11. Molecular assessment of testicular adult granulosa cell tumor demonstrates significant differences when compared to ovarian counterparts.
Siegmund S; Sholl LM; Cornejo KM; Sangoi AR; Otis CN; Mehra R; Hirsch MS; Acosta AM
Mod Pathol; 2022 May; 35(5):697-704. PubMed ID: 34845303
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic analysis of stage 1 versus advanced adult granulosa cell tumors.
Alexiadis M; Chu S; Leung D; Gould JA; Jobling T; Fuller PJ
Oncotarget; 2016 Mar; 7(12):14207-19. PubMed ID: 26893359
[TBL] [Abstract][Full Text] [Related]
13. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp.
Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL
Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437
[TBL] [Abstract][Full Text] [Related]
14. High-grade Transformation in Adult Granulosa Cell Tumor: Potential Diagnostic Challenges and the Utility of Molecular Testing.
Mubeen A; Martin I; Dhall D
Int J Surg Pathol; 2022 Sep; 30(6):668-672. PubMed ID: 35118890
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Granulosa Cell Tumor Initially Presenting as a Giant Liver Mass Radiologically Mimicking Primary Cystic Cholangiocarcinoma.
Qian X; Cong Z; Lai J
In Vivo; 2023; 37(2):734-737. PubMed ID: 36881092
[TBL] [Abstract][Full Text] [Related]
16. Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas J; Hurtado A; Garrigos L; Santaballa A; Redondo A; Vidal L; Lainez N; Guerra E; Rodriguez V; Cueva J; Bover I; Palacio I; Rubio MJ; Prieto M; Lopez-Guerrero JA; Rodriguez-Moreno JF; Garcia-Casado Z; Garcia-Martinez E; Taus A; de Castro IP; Navarro P; Grande E;
Clin Transl Oncol; 2023 Jul; 25(7):2090-2098. PubMed ID: 36708371
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
[TBL] [Abstract][Full Text] [Related]
18. Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup.
Roze J; Monroe G; Kutzera J; Groeneweg J; Stelloo E; Paijens S; Nijman H; Meurs HV; Lonkhuijzen LV; Piek J; Lok C; Jonges G; Witteveen P; Verheijen R; Haaften GV; Zweemer R
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32455687
[TBL] [Abstract][Full Text] [Related]
19. Ovarian juvenile granulosa cell tumors with Ollier's disease in children with IDH1 gene somatic mutation.
Zhang J; Hua R; Ma L; Liu C; Zhang Y; Lü X; Wang T; Wan N
Front Endocrinol (Lausanne); 2023; 14():1093273. PubMed ID: 37324278
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical markers of prognosis in adult granulosa cell tumors of the ovary - a review.
Jung D; Almstedt K; Battista MJ; Seeger A; Jäkel J; Brenner W; Hasenburg A
J Ovarian Res; 2023 Mar; 16(1):50. PubMed ID: 36869369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
